Methyl 4-(3-amino-4-(4-methoxyphenyl)-6-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-2-yl)benzoate

ID: ALA5170342

Chembl Id: CHEMBL5170342

PubChem CID: 168270302

Max Phase: Preclinical

Molecular Formula: C21H20N4O4

Molecular Weight: 392.42

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(-n2nc3c(c2N)C(c2ccc(OC)cc2)CC(=O)N3)cc1

Standard InChI:  InChI=1S/C21H20N4O4/c1-28-15-9-5-12(6-10-15)16-11-17(26)23-20-18(16)19(22)25(24-20)14-7-3-13(4-8-14)21(27)29-2/h3-10,16H,11,22H2,1-2H3,(H,23,24,26)

Standard InChI Key:  PEYLWAYQXYSRAF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5170342

    ---

Associated Targets(Human)

MKNK2 Tchem MAP kinase-interacting serine/threonine-protein kinase 1/2 (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.42Molecular Weight (Monoisotopic): 392.1485AlogP: 2.72#Rotatable Bonds: 4
Polar Surface Area: 108.47Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.20CX Basic pKa: 1.87CX LogP: 2.72CX LogD: 2.72
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.66Np Likeness Score: -0.66

References

1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S..  (2022)  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.,  65  (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941]

Source